Breast Cancer

Papers
(The H4-Index of Breast Cancer is 23. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Hereditary breast and ovarian cancer (HBOC): review of its molecular characteristics, screening, treatment, and prognosis109
The frequency of low HER2 expression in breast cancer and a comparison of prognosis between patients with HER2-low and HER2-negative breast cancer by HR status84
Health-related quality of life following breast reconstruction compared to total mastectomy and breast-conserving surgery among breast cancer survivors: a systematic review and meta-analysis68
Prognostic significance and targeting tumor-associated macrophages in cancer: new insights and future perspectives60
A machine learning-based radiomics model for the prediction of axillary lymph-node metastasis in breast cancer46
The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2018 edition42
Tumor-infiltrating regulatory T cells, CD8/Treg ratio, and cancer stem cells are correlated with lymph node metastasis in patients with early breast cancer37
Patient and clinician satisfaction and clinical outcomes of Magseed compared with wire-guided localisation for impalpable breast lesions34
High absolute lymphocyte counts are associated with longer overall survival in patients with metastatic breast cancer treated with eribulin—but not with treatment of physician’s choice—in the EMBRACE 31
Axillary surgery for breast cancer: past, present, and future31
Annual report of the Japanese Breast Cancer Registry for 201729
The prognosis of invasive ductal carcinoma, lobular carcinoma and mixed ductal and lobular carcinoma according to molecular subtypes of the breast27
Prognostic value of tumor-infiltrating B lymphocytes and plasma cells in triple-negative breast cancer26
Friend or foe: ABCG2, ABCC1 and ABCB1 expression in triple-negative breast cancer26
The dynamic change of neutrophil to lymphocyte ratio is predictive of pathological complete response after neoadjuvant chemotherapy in breast cancer patients26
Prognostic values of clinical and molecular features in HER2 low-breast cancer with hormonal receptor overexpression: features of HER2-low breast cancer25
Prediction of Oncotype DX recurrence score using deep multi-layer perceptrons in estrogen receptor-positive, HER2-negative breast cancer25
Associations of adiposity and weight change with recurrence and survival in breast cancer patients: a systematic review and meta-analysis24
Triple-negative breast cancer incidence in the United States: ecological correlations with area-level sociodemographics, healthcare, and health behaviors24
Unmet needs in breast cancer survivors are common, and multidisciplinary care is underutilised: the Survivorship Needs Assessment Project24
Circular RNAs serve as miRNA sponges in breast cancer24
Inhibition of Cdc20 suppresses the metastasis in triple negative breast cancer (TNBC)23
Immune-related biomarkers in triple-negative breast cancer23
0.022363185882568